The way in which products are developed and approved may need to adapt to the rapid changes taking place in the field of targeted therapies and companion diagnostics . Reimbursement systems were developed to suit the traditional model of healthcare delivery and, in many cases, do not take full account of the value that personalised healthcare can add.
Data protection will also be essential. It is vital that rules on data protection safeguard individual privacy while permitting scientific sharing of data.
For the full potential of personalised medicine to be realised, healthcare professionals and the general public must embrace these new technologies. Multidisciplinary training for healthcare professionals and public awareness campaigns can improve understanding and confidence.